Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate Free

Abstract

The effect on the nasopharyngeal bacterial flora of 10 days of amoxycillin-clavulanate or cefdinir antimicrobial therapy was studied in 50 children with acute otitis media. Before therapy, 17 potential pathogens (, and ) were isolated from the nasopharynx of 14 (56 %) of those treated with amoxycillin-clavulanate, and 20 potential pathogens were recovered from 15 (60 %) of those treated with cefdinir. Following therapy, at days 12–15, the number of potential pathogens was reduced to a similar extent with both therapies, to three in those treated with amoxycillin-clavulanate and two in those treated with cefdinir. However, the number of potential pathogens rebounded faster in those treated with amoxycillin-clavulanate as compared with cefdinir in the two subsequent specimens taken at days 30–35 and 60–65 (12 and 18 in the amoxycillin-clavulanate group, and six and nine in the cefdinir group, < 0.01 and < 0.001, respectively). Differences between the groups were also noted in the recovery of organisms with interfering capability. Immediately following amoxycillin-clavulanate therapy, the number of interfering organisms declined from 54 to 13, while following cefdinir treatment their number was reduced from 59 to 39 ( < 0.001). The differences between the two therapy groups persisted in the two later specimens taken at days 30–35 and 60–65 (25 and 38 in the amoxycillin-clavulanate group, and 52 and 51 in the cefdinir group, < 0.001 and < 0.05, respectively). This study illustrates the potential beneficial effect of using a narrow-spectrum antimicrobial that selectively spares the interfering organisms while eliminating pathogens. The benefit of such therapy is the prevention of reacquisition of pathogenic bacteria in the nasopharynx. In contrast, utilization of a broad-spectrum antimicrobial is associated with prolonged absence of inhibitory organisms and rapid recolonization with pathogens.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45837-0
2005-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/6/JM540608.html?itemId=/content/journal/jmm/10.1099/jmm.0.45837-0&mimeType=html&fmt=ahah

References

  1. Bernstein J. M., Sagahtaheri-Altaie S., Dryjd D. M., Wactawski-Wende J. 1994; Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol Belg 48:1–9
    [Google Scholar]
  2. Brook I. 1999; Bacterial interference. Crit Rev Microbiol 25:155–72 [CrossRef]
    [Google Scholar]
  3. Brook I. 2001; The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 17:439–42 [CrossRef]
    [Google Scholar]
  4. Brook I., Gilmore J. D. 1993; Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci. Antimicrob Agents Chemother 37:1452–1455 [CrossRef]
    [Google Scholar]
  5. Brook I., Gober A. E. 1995; Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg 121:1405–1409 [CrossRef]
    [Google Scholar]
  6. Brook I., Gober A. E. 2000; In vitro bacterial interference in the nasopharynx of otitis media-prone and non-otitis media-prone children. Arch Otolaryngol Head Neck Surg 126:1011–1013 [CrossRef]
    [Google Scholar]
  7. Faden H., Zaz M. J., Bernstein J. M., Brodsky L., Stamievich J., Ogru P. L. 1991; Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol 100:612–615 [CrossRef]
    [Google Scholar]
  8. Foote P. A. Jr, Brook I. 1989; Penicillin and clindamycin therapy in recurrent tonsillitis.Effect of microbiol flora. Arch Otolaryngol Head Neck Surg 115:856–859 [CrossRef]
    [Google Scholar]
  9. Guay D. R. 2000; Cefdinir: an expanded-spectrum oral cephalosporin. Ann Pharmacother 34:1469–1477 [CrossRef]
    [Google Scholar]
  10. Mackowiak P. A. 1982; The normal flora. N Engl J Med 307:83–93 [CrossRef]
    [Google Scholar]
  11. Murray P. R., Rosenblatt J. E. 1976; Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria. J Infect Dis 134:281–285 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45837-0
Loading
/content/journal/jmm/10.1099/jmm.0.45837-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed